Predicting lung adenocarcinoma (LUAD) risk is crucial in determining further treatment strategies. Molecular biomarkers may improve risk stratification for LUAD. | A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies